Moderna Therapeutics
Christopher Aviles is a seasoned finance professional currently serving as a Senior Accountant - GL at Moderna since December 2023. Prior to this role, Christopher held positions at Microsoft as a Senior Accountant from February 2022 to November 2023 and at Raytheon Missiles & Defense as a Principal Program Cost Controls Analyst for a brief period in 2021. Christopher's tenure at Raytheon Technologies included roles as a Senior Financial Analyst and Financial Analyst II from April 2018 to October 2021. Earlier experience includes serving as a Senior Accountant and Staff Accountant at Leader Bank between June 2014 and April 2018. Christopher Aviles earned a Bachelor of Science in Accounting and Finance from UMass Boston, where studies were completed from 2009 to 2014.
This person is not in any teams
This person is not in any offices
Moderna Therapeutics
125 followers
Moderna Therapeutics is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA.